Skip to main content
. 2020 Jul 21;4(4):e424. doi: 10.1097/HS9.0000000000000424

Table 1.

Criteria for Ruxolitinib Failure Used in the Re-analysis of JAKARTA-2,60 PAC20371 and FREEDOM Trials.

graphic file with name hs9-4-e424-g001.jpg